Transcriptome profiling in response to adiponectin in human cancer-derived cells. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Physiological Genomics Année : 2010

Transcriptome profiling in response to adiponectin in human cancer-derived cells.

Résumé

Berger E, Rome S, Vega N, Ciancia C, Vidal H. Transcriptome profiling in response to adiponectin in human cancer-derived cells. Physiol Genomics 42A: 61-70, 2010. First published June 22, 2010; doi:10.1152/physiolgenomics.00013.2010.-The adipocyte-derived hormone adiponectin exerts protective actions in several disorders, including some cancers. However, while growing data suggest that adiponectin could be an effective anticancer agent, its mechanism of action in cancer cells is still poorly known. Here, using microarrays, we identified a set of 1,301 genes commonly modulated in three cancer-derived cell lines in response to short-term stimulation with full-length recombinant human adiponectin. Most of these genes are involved in translation regulation, immune or stress responses, and cell proliferation. Furthermore, among genes linked to disease that were retrieved by functional enrichment tests using text mining based on PubMed analysis, we found that 66% are involved in malignant neoplasms, further supporting the link between adiponectin and cancer mechanisms. Bioinformatic analysis demonstrated the diversity of signaling pathways and transcription factors potentially mediating adiponectin effects on gene expression, illustrating the complexity of adiponectin mechanisms of action in cancer cells.
Fichier non déposé

Dates et versions

hal-01837861 , version 1 (12-07-2018)

Identifiants

Citer

Emmanuelle Berger, Sophie Rome, Nathalie Vega, Claire Ciancia, Hubert Vidal. Transcriptome profiling in response to adiponectin in human cancer-derived cells.. Physiological Genomics, 2010, 42A (1), pp.61-70. ⟨10.1152/physiolgenomics.00013.2010⟩. ⟨hal-01837861⟩
37 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More